SCYNEXIS Resumes Patient Dosing in Phase 3 MARIO Study
Go back to SCYNEXIS Resumes Patient Dosing in Phase 3 MARIO Study| SCYNEXIS (NASDAQ: SCYX) | Delayed: 5.30 -0.04 (0.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.34 | 52 Week High | $7.29 | |||
| Open | $5.31 | 52 Week Low | $1.74 | |||
| Day High | $5.45 | P/E | N/A | |||
| Day Low | $5.18 | EPS | $0.00 | |||
| Volume | 55,500 | |||||
